ADT: No Help as Primary Tx for Prostate Cancer

(MedPage Today) -- Primary androgen deprivation therapy offered no survival benefit to prostate cancer patients with localized disease who opted not to have surgery or radiation therapy, data from a large retrospective cohort showed.
Source: MedPage Today State Required CME - Category: Consumer Health News Source Type: news